Next Phase for Karolinksa

Early stage biotech investor Karolinska Developmentis looking to go public to enable it to support its portfolio through early 2014. By then, it expects to see enough M&A, IPO and partnership activity to be cash flow positive.

Karolinska last week filed to raise SEK421.8-SEK478.8 million ($66-$74.9 million) through the sale of up to 11.4 million shares at SEK37-SEK42 in an IPO on NASDAQ OMX Stockholm...